International Isotopes Inc. Files 8-K
Ticker: INIS · Form: 8-K · Filed: Dec 31, 2025 · CIK: 1038277
Sentiment: neutral
Topics: corporate-filing, amendment, financials
Related Tickers: INIS
TL;DR
INIS filed an 8-K on 12/23/25 covering corporate changes and financials.
AI Summary
International Isotopes Inc. filed an 8-K on December 23, 2025, reporting on amendments to its articles of incorporation or bylaws, other events, and financial statements. The filing details the company's principal executive offices located at 4137 Commerce Circle, Idaho Falls, ID 83401, with a business phone number of 208-524-5300.
Why It Matters
This 8-K filing provides an update on International Isotopes Inc.'s corporate structure and financial reporting, which is crucial for investors to understand the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks.
Key Players & Entities
- INTERNATIONAL ISOTOPES INC. (company) — Registrant
- 4137 Commerce Circle, Idaho Falls, ID 83401 (location) — Principal Executive Offices
- 208-524-5300 (phone_number) — Business Phone
- December 23, 2025 (date) — Date of earliest event reported
FAQ
What specific amendments were made to the articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary information.
What are the 'Other Events' reported in this 8-K?
The filing lists 'Other Events' as an item information, but the nature of these events is not detailed in the provided text.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on December 23, 2025.
What is the primary business address of International Isotopes Inc.?
The primary business address is 4137 Commerce Circle, Idaho Falls, ID 83401.
What is the telephone number for International Isotopes Inc.?
The registrant's telephone number, including area code, is 208-524-5300.
Filing Stats: 618 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-12-31 09:30:11
Filing Documents
- inis20251230_8k.htm (8-K) — 25KB
- ex_903318.htm (EX-99.1) — 11KB
- a01.jpg (GRAPHIC) — 9KB
- a02.jpg (GRAPHIC) — 10KB
- a03.jpg (GRAPHIC) — 5KB
- 0001437749-25-039001.txt ( ) — 193KB
- inis-20251223.xsd (EX-101.SCH) — 3KB
- inis-20251223_def.xml (EX-101.DEF) — 10KB
- inis-20251223_lab.xml (EX-101.LAB) — 14KB
- inis-20251223_pre.xml (EX-101.PRE) — 11KB
- inis20251230_8k_htm.xml (XML) — 3KB
03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On December 23, 2025, International Isotopes Inc. ("we," "our," "us," or the "Company") filed a Certificate of Amendment in the state of Texas for the sole purpose of amending our Certificate of Formation to change our corporate name from International Isotopes Inc. to Radnostix, Inc. (the " Name Change "). As was previously disclosed on a Schedule 14C Information Statement filed by the Company with the Securities and Exchange Commission on November 26, 2025, our board of directors approved the Name Change on October 21, 2025, and a majority of shareholders approved the Name Change by written consent on November 25, 2025. The Name Change was implemented because our line of business has expanded from providing radiochemicals and non-medical radioisotopes and a focus on energy-sector related isotopes to providing a broader portfolio of radioisotope, theranostics, and related products, devices, and accessories, mainly focused on healthcare applications. We believe that Radnostix, Inc. better reflects our focus on radiosiotopes and theranostics going forward. At this time, our common stock will continue to trade under the current ticket symbol "INIS" on the OTCQB marketplace. Shareholders are not required to take any action regarding their stock certificates as a result of the name change.
01 Other Events
Item 8.01 Other Events. On December 31, 2025, the Company issued a press release announcing the Name Change. A copy of the press release is attached here as Exhibit 99.1 and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release regarding Name Change dated December 31, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 31, 2025 INTERNATIONAL ISOTOPES INC. By: /s/ Shahe Bagerdjian Name: Shahe Bagerdjian Title: President and Chief Executive Officer